You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

progressive multiple sclerosis

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Sclerosis, Progressive Multiple Sclerosis Trial in Bergen (Nicotinamid riboside, Placebo)

Not yet recruiting
  • Multiple Sclerosis
  • Progressive Multiple Sclerosis
  • Nicotinamid riboside
  • Placebo
  • Bergen, Norway
    Haukeland University Hospital
Feb 22, 2023

Mitochondrial Dysfunction in Primary Progressive Multiple

Recruiting
  • Multiple Sclerosis
    • Milan, MI, Italy
    • +1 more
    Aug 29, 2023

    Mayzent Onboarding of Secondary Progressive Multiple Sclerosis

    Completed
    • Secondary Progressive Multiple Sclerosis
      • Camperdown, New South Wales, Australia
      • +1 more
      Apr 19, 2023

      Multiple Sclerosis Trial (Frexalimab, Placebo, MRI contrast-enhancing agents)

      Not yet recruiting
      • Multiple Sclerosis
      • (no location specified)
      Nov 15, 2023

      Progressive Multiple Sclerosis Trial in Genova, Roma (Osmotin)

      Recruiting
      • Progressive Multiple Sclerosis
      • Osmotin
      • Genova, Italy
      • +1 more
      Jun 30, 2023

      Ocrelizumab on Choroid Plexus Changes in Patients With PPMS

      Not yet recruiting
      • Primary Progressive Multiple Sclerosis
      • Ocrelizumab
      • Buffalo, New York
        Buffalo Neuroimaging Analysis Center
      Jul 26, 2023

      Progressive Multiple Sclerosis Trial (Transcranial static magnetic field stimulation (tSMS), Sham Transcranial static magnetic

      Not yet recruiting
      • Progressive Multiple Sclerosis
      • Transcranial static magnetic field stimulation (tSMS)
      • Sham Transcranial static magnetic field stimulation (tSMS)
      • (no location specified)
      Mar 30, 2023

      Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis Trial in Warsaw (Cladribine Subcutaneous Injection, 0.9% Chloride

      Recruiting
      • Multiple Sclerosis, Secondary Progressive
      • Multiple Sclerosis
      • Cladribine Subcutaneous Injection
      • 0.9% Chloride Injection Sodium
      • Warsaw, Mazowieckie, Poland
        Institute of Psychiatry and Neurology
      Jul 26, 2023

      Microglia in the Pathogenesis of Progressive Multiple Sclerosis

      Active, not recruiting
      • Multiple Sclerosis
        • Turku, Finland Proper, Finland
          Turku PET Centre
        Oct 12, 2022

        Multiple Sclerosis, Primary Progressive Multiple Sclerosis, Secondary-progressive Multiple Sclerosis Trial in Belgium (Metformin

        Not yet recruiting
        • Multiple Sclerosis
        • +2 more
        • Metformin Hydrochloride 850 mg Oral Tablet
        • Placebo
        • Brugge, Belgium
        • +4 more
        May 30, 2023

        Ocrelizumab on Cortical Lesion Accumulation in PPMS

        Not yet recruiting
        • Primary Progressive Multiple Sclerosis
        • Ocrelizumab
        • (no location specified)
        Aug 2, 2023

        Multiple Sclerosis, Chronic Progressive, High-Intensity Interval Training, Motor Symptoms Trial in Valens (HIIT, MCT)

        Recruiting
        • Multiple Sclerosis, Chronic Progressive
        • +2 more
        • HIIT
        • MCT
        • Valens, Sankt Gallen, Switzerland
          Klinik Valens, Valens rehabilitation clinic
        Oct 12, 2022

        Progressive Multiple Sclerosis Trial in Ghent (Bytelfies kit - sensor dot)

        Recruiting
        • Progressive Multiple Sclerosis
        • Bytelfies kit - sensor dot
        • Ghent, Oost-Vlaanderen, Belgium
          University Hospital Ghent
        Jan 5, 2023

        Multiple Sclerosis Trial (Siponimod)

        Available
        • Multiple Sclerosis
        • (no location specified)
        Sep 13, 2022

        Progressive Multiple Sclerosis Trial in Regina (Exercise Group 1, Exercise Group 2, Exercise Group 3)

        Recruiting
        • Progressive Multiple Sclerosis
        • Exercise Group 1
        • +2 more
        • Regina, Saskatchewan, Canada
          University of Regina
        Aug 8, 2022

        Secondary-progressive Multiple Sclerosis Trial in Buffalo (Mayzent, Ocrevus)

        Recruiting
        • Secondary-progressive Multiple Sclerosis
        • Buffalo, New York
          University at Buffalo, Buffalo General Hospital
        Oct 10, 2022

        Progressive Multiple Sclerosis Trial in Lille, Strasbourg (Placebo, Masitinib (4.5))

        Recruiting
        • Progressive Multiple Sclerosis
        • Placebo
        • Masitinib (4.5)
        • Lille, France
        • +1 more
        Jul 1, 2022

        Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis Trial in Los Angeles (Metformin 500 Mg Oral

        Recruiting
        • Secondary Progressive Multiple Sclerosis
        • Primary Progressive Multiple Sclerosis
        • Metformin 500 Mg Oral Tablet, up to 4 tablets a day
        • Placebo oral tablet identical to metformin, up to 4 tablets a day
        • Los Angeles, California
          University of California, Los Angeles
        May 2, 2022

        Progressive Multiple Sclerosis Trial in Berlin (GZ402668, Placebo, Acyclovir)

        Completed
        • Progressive Multiple Sclerosis
        • Berlin, Germany
          Investigational Site Number 276001
        Apr 22, 2022

        Multiple Sclerosis, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive Trial in San Francisco

        Recruiting
        • Multiple Sclerosis
        • +2 more
        • N-acetyl cysteine
        • Placebo
        • San Francisco, California
          University of California, San Francisco
        Mar 22, 2022

        Progressive Multiple Sclerosis, Fatigue Trial in San Francisco (N-acetyl cysteine, Placebo)

        Completed
        Has Results
        • Progressive Multiple Sclerosis
        • Fatigue
        • N-acetyl cysteine
        • Placebo
        • San Francisco, California
          University of California San Francisco
        Sep 6, 2022

        Relapsing Remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis Trial in Birmingham, Saint Louis (Glycemic

        Not yet recruiting
        • Relapsing Remitting Multiple Sclerosis
        • Secondary Progressive Multiple Sclerosis
        • Glycemic load
        • +2 more
        • Birmingham, Alabama
        • +1 more
        Jan 4, 2023

        Gray Matter Demyelination in Primary Progressive MS at 7T

        Recruiting
        • Primary Progressive Multiple Sclerosis
          • Hvidovre, Denmark
            Danish Research Centre for Magnetic Resonance
          Jun 5, 2022

          Multiple Sclerosis, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive Trial in Palo Alto

          Not yet recruiting
          • Multiple Sclerosis
          • +2 more
          • KYV-101 anti-CD19 CAR-T cell therapy
          • Standard lymphodepletion regimen
          • Palo Alto, California
            Stanford Multiple Sclerosis Center
          Nov 13, 2023

          Multiple Sclerosis Trial in Canada, United States (Lipoic acid, Placebo)

          Active, not recruiting
          • Multiple Sclerosis
          • Lipoic acid
          • Placebo
          • Birmingham, Alabama
          • +10 more
          Jan 31, 2023